4.6 Article

Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

Journal

CANCERS
Volume 13, Issue 10, Pages -

Publisher

MDPI
DOI: 10.3390/cancers13102370

Keywords

breast cancer; estrogen; gene-environment interaction

Categories

Funding

  1. Seoul National University Hospital
  2. Seoul National University Hospital Research Fund [0320150110 (2015-1126)]
  3. Cancer Research UK [C1287/A16563, C1287/A10118, C1287/A10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565, C490/A10124, C490/A16561]
  4. European Union [634935, 633784]
  5. European Community [223175, HEALTH-F2-2009-223175]
  6. Cancer UK [C1287/A16563]
  7. Government of Canada through Genome Canada
  8. Canadian Institutes of Health Research [GPH-129344]
  9. Ministere de l'Economie, Science et Innovation du Quebec through Genome Quebec
  10. Quebec Breast Cancer Foundation
  11. European Community's Seventh Framework Programme [223175 (HEALTH-F2-2009-223175)]
  12. National Institutes of Health [CA128978]
  13. Department of Defence [W81XWH-10-1-0341]
  14. Canadian Institutes of Health Research (CIHR)
  15. Komen Foundation for the Cure
  16. Breast Cancer Research Foundation
  17. Ovarian Cancer Research Fund
  18. National Cancer Institute (USA) [UM1 CA164920]
  19. National Health and Medical Research Council of Australia
  20. New South Wales Cancer Council
  21. Victorian Health Promotion Foundation (Australia)
  22. Victorian Breast Cancer Research Consortium
  23. Dutch Cancer Society [RUL 1997-1505, NKI 2007-3839, 2009 4363]
  24. Breast Cancer Research Trust, UK
  25. NIHR Manchester Biomedical Research Centre
  26. Allan Turing Institute under the EPSRC [EP/N510129/1]
  27. ELAN-Fond of the University Hospital of Erlangen
  28. Fondation de France
  29. Institut National du Cancer (INCa)
  30. Ligue Nationale contre le Cancer
  31. Agence Nationale de la Recherche (ANR)
  32. Chief Physician Johan Boserup and Lise Boserup Fund
  33. Danish Medical Research Council
  34. Herlev and Gentofte Hospital
  35. Instituto de Salud Carlos III
  36. Red Tematica de Investigacion Cooperativa en Cancer
  37. Asociacion Espanola Contra el Cancer
  38. Fondo de Investigacion Sanitario [PI11/00923, PI12/00070]
  39. American Cancer Society
  40. National Cancer Institute of the National Institutes of Health [U01-CA199277, P30-CA033572, P30-CA023100, UM1-CA164917, R01CA077398]
  41. California Department of Public Health [103885]
  42. Centers for Disease Control and Prevention's National Program of Cancer Registries [5NU58DP006344]
  43. National Cancer Institute's Surveillance, Epidemiology and End Results Program [HHSN261201800032I, HHSN261201800015I, HHSN261201800009I]
  44. Baden Wurttemberg Ministry of Science, Research and Arts
  45. Robert Bosch Foundation, Stuttgart
  46. Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany
  47. Breast Cancer Now
  48. CRUK
  49. Helsinki University Hospital Research Fund
  50. Finnish Cancer Society
  51. Sigrid Juselius Foundation
  52. MEXT Kakenhi from the Ministry of Education, Science, Sports, Culture and Technology of Japan [170150181, 26253041]
  53. Ministry Health, Labour, and Welfare of Japan
  54. Ministry Health of Labour and Welfare of Japan
  55. National Cancer Center Research and Development Fund
  56. Japan Agency for Medical Research and development, AMED [15ck0106177h0001, 20ck0106553]
  57. Cancer Bio Bank Aichi
  58. German Research Foundation [Do 761/10-1]
  59. Biomedical Research Centre at Guy's and St Thomas' N.H.S. Foundation Trust and King's College London
  60. Stockholm County Council
  61. Karolinska Institutet
  62. Swedish Cancer Society
  63. Gustav V Jubilee foundation
  64. Bert von Kantzows foundation
  65. Marit and Hans Rausings Initiative Against Breast Cancer
  66. special Government Funding (VTR) of Kuopio University Hospital grants
  67. Cancer Fund of North Savo
  68. Finnish Cancer Organizations
  69. University of Eastern Finland
  70. National Breast Cancer Foundation
  71. Queensland Cancer Fund
  72. Cancer Council of South Australia
  73. Cancer Foundation of Western Australia
  74. United States Army Medical Research and Materiel Command [DAMD17-01-1-0729]
  75. Cancer Council New South Wales
  76. Cancer Council South Australia
  77. Cancer Foundation ofWestern Australia
  78. Cancer Council Tasmania
  79. National Health and Medical Research Council of Australia (NHMRC) [400413, 400281, 199600]
  80. NHMRC
  81. Cancer Australia
  82. National Institute of Health (USA)
  83. California Breast Cancer Research Program [1RB-0287, 3PB-0102, 5PB-0018, 10PB-0098]
  84. California Department of Health
  85. National Cancer Institute's Division of Cancer Prevention and Control Surveillance, Epidemiology, and End Results Program [N01CN25403]
  86. Stichting tegen Kanker
  87. FWO
  88. Deutsche Krebshilfe e.V. [70-2892-BR I, 106332, 108253, 108419, 110826, 110828]
  89. Hamburg Cancer Society
  90. German Cancer Research Center (DKFZ)
  91. Federal Ministry of Education and Research (BMBF) Germany [01KH0402, 01KW9975/5, 01KW9976/8, 01KW9977/0, 01KW0114]
  92. Italian Association for Cancer Research (AIRC)
  93. NIH [R01CA64277, R01CA148667, UMCA182910, R37CA70867, U19 CA148065, R35CA253187, R01CA192393, R01CA116167, R01CA176785, CA63464, CA54281, CA098758, CA132839, CA164973, R01CA100374]
  94. NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer [P50CA116201]
  95. VicHealth
  96. Australian National Health and Medical Research Council [209057, 396414, 1074383]
  97. Cancer Council Victoria
  98. Malaysian Ministry of Higher Education [RP046B-15HTM, UM.C/HlR/MOHE/06]
  99. Cancer Research Malaysia
  100. Yayasan Sime Darby LPGA Tournament
  101. K.G. Jebsen Centre for Breast Cancer Research
  102. Research Council of Norway [193387/V50, 193387/H10]
  103. Norwegian Cancer Society
  104. Finnish Cancer Foundation
  105. Academy of Finland [250083, 122715, 251314]
  106. University of Oulu
  107. University of Oulu Support Foundation
  108. special Governmental EVO funds for Oulu University Hospital-based research activities
  109. U.S. National Cancer Institute of the National Institutes of Health [U01CA164920, U01CA167551]
  110. Biobanking and Biomolecular Resources Research Infrastructure [BBMRI-NL CP16]
  111. Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA
  112. Agency for Science, Technology and Research of Singapore (A*STAR.)
  113. U.S. National Institute of Health (NIH)
  114. Susan G. Komen Breast Cancer Foundation
  115. Genetic Associations and Mechanisms in Oncology (GAME-ON) Network [U19 CA148065]
  116. Sheffield Experimental Cancer Medicine Centre
  117. UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge
  118. BRL (Basic Research Laboratory) program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2012-0000347]
  119. National Research Foundation Singapore
  120. National University Cancer Institute Singapore (NCIS) Centre Grant
  121. Breast Cancer Prevention Programme
  122. Biomedical Research Council [05/1/21/19/425]
  123. Taiwan Biobank project of the Institute of Biomedical Sciences, Academia Sinica, Taiwan
  124. Institute of Cancer Research (ICR), London
  125. NHS
  126. Institute of Cancer Research
  127. Manchester NIHR Biomedical Research Centre [IS-BRC-1215-20007]
  128. Cancer Research UK
  129. Agence Nationale de Securite Sanitaire, de l'Alimentation, de l'Environnement et du Travail (ANSES)
  130. German Cancer Aid (Deutsche Krebshilfe)
  131. Deutsches Krebsforschungszentrum (DKFZ), Heidelberg
  132. Post-Cancer GWAS initiative (GAME-ON initiative) [1U19 CA148537, 1U19 CA148065, 1U19 CA148112]
  133. Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum
  134. Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London
  135. National Health and Medical Research Council (NHMRC)
  136. Cancer Council of New South Wales
  137. Cancer Council of Victoria
  138. Cancer Council of Tasmania
  139. South Eastern Norway Health Authority [39346]
  140. Breast Cancer Now Tissue Bank
  141. NUS
  142. Asian Breast Cancer Research Fund
  143. NMRC Clinician Scientist Award (SI Category)
  144. DF.Z
  145. [PSRSIIRI-701]
  146. [P30 CA68485]
  147. Grants-in-Aid for Scientific Research [26253041] Funding Source: KAKEN

Ask authors/readers for more resources

The study focused on gene-environment interactions related to estrogen exposure or metabolism in Korean women, finding two interactions that were not replicated in a larger European and Asian population. This highlights the specificity of breast cancer risk in Koreans.
Simple Summary Breast cancer is the most common cancer in females worldwide. To date, many gene-environment interaction (GxE) studies have been conducted to better understand how genetic factors combine with environmental factors to influence risk. However, previous studies have not found or found only a few interactions by using SNPs which were discovered from genome-wide association studies and have been conducted, for the most part, within European populations. In this study, we focused on estrogen-related lifestyle factors that have been identified for breast cancer, including several well-established reproductive factors that are mediated by hormonal mechanisms. We aimed to examine whether there are any gene and environmental factor interactions related to estrogen exposure or metabolism using a candidate approach in Korean women. We found two interactions in this study, although they were not replicated in the independent large consortium data. These findings suggest specificity in Koreans for breast cancer risk. In this study we aim to examine gene-environment interactions (GxEs) between genes involved with estrogen metabolism and environmental factors related to estrogen exposure. GxE analyses were conducted with 1970 Korean breast cancer cases and 2052 controls in the case-control study, the Seoul Breast Cancer Study (SEBCS). A total of 11,555 SNPs from the 137 candidate genes were included in the GxE analyses with eight established environmental factors. A replication test was conducted by using an independent population from the Breast Cancer Association Consortium (BCAC), with 62,485 Europeans and 9047 Asians. The GxE tests were performed by using two-step methods in GxEScan software. Two interactions were found in the SEBCS. The first interaction was shown between rs13035764 of NCOA1 and age at menarche in the GE|2df model (p-2df = 1.2 x 10(-3)). The age at menarche before 14 years old was associated with the high risk of breast cancer, and the risk was higher when subjects had homozygous minor allele G. The second GxE was shown between rs851998 near ESR1 and height in the GE|2df model (p-2df = 1.1 x 10(-4)). Height taller than 160 cm was associated with a high risk of breast cancer, and the risk increased when the minor allele was added. The findings were not replicated in the BCAC. These results would suggest specificity in Koreans for breast cancer risk.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available